![Dr. Maris in lab](/sites/default/files/styles/search_image_256x256/public/dr-maris-in-lab-780x439.jpg?itok=IMzRFmyP)
Pinpointing Mutations in a Relapsed Cancer May Lead to Better Treatments
Jun 29, 2015
CHOP neuroblastoma researchers have detailed how cancer-driving mutations evolve during chemotherapy, and they aim to exploit this knowledge to design better treatments for children.